siRNA therapy lowers triglycerides in individuals with uncommon disorder

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran lowered triglyceride levels through 80% and reduced the risk of pancreatitis in individuals along with relentless chylomicronemia, along with or without a hereditary diagnosis.